At a glance
ClinicalIndex Comparison RecordN/ACompleted· 724,428 enrolled
Drug / intervention
Biological (Male Wolbachia-infected Aedes aegypti)biological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessing the Efficacy of Male Wolbachia-infected Mosquito Deployments to Reduce Dengue Incidence in Singapore: a Cluster Randomized Controlled Trial
In Brief
A clinical study evaluating Biological (Male Wolbachia-infected Aedes aegypti) for Dengue. Completed, enrolled 724,428 participants across 1 site.
Detailed Summary
The study is a cluster-randomised controlled trial set in Singapore, to assess if the deployment of male Wolbachia-infected Aedes aegypti mosquitoes can reduce dengue incidence in intervention clusters.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDengue
CountriesSingapore
CollaboratorsMinistry of Health, Singapore
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartJul 2022
First PostedAug 2022
Primary CompletionSep 2024
TodayJul 2026
First PostedAug 18, 2022
Enrollment StartJul 28, 2022
Primary CompletionSep 13, 2024
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 3.9 years ago
Interventions
Biological (Male Wolbachia-infected Aedes aegypti)biological
Releases of male Wolbachia-infected Aedes aegypti mosquitoes